What's breaking now, across thousands of outlets.
New federal guidance urges employers to stock opioid reversal medication and train workers to use it, even as fentanyl detection declines.
We haven't written up this one. Inc. has the full story — the link below goes straight to it.
The deal would yield a roughly $12.5 billion, multi-state integrated nonprofit with 22 hospitals and a 1.6 million-member insurance business.
The deal, which hands Novo a challenger to Lilly’s market-leading Zepbound, comes as the Danish drugmaker looks to calm investor fears about its future.
The Maharashtra FDA has suspended licences or ordered action against 13 Mumbai food establishments after inspections found serious hygiene lapses, including pest infestations, unsafe food storage and…
The 10th century treatment called Bald’s eyesalve attacks microbes in multiple ways. Molecule mixtures from it may inspire modern medicine.
Attention-deficit/hyperactivity disorder (ADHD) is often discussed in terms of visible traits: fidgeting, distractibility, forgetfulness or restlessness. But those are just the traits we can see.
Researcher Tinne Laurberg told Newsweek that the gap has become "more pronounced in recent years."
